BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Tuesday, April 14, 2026
Home » Topics » Briefs

Briefs
Briefs RSS Feed RSS

Other news to note for March 3, 2026

March 3, 2026
Biopharma and med-tech happenings in Asia-Pacific, including deals and partnerships, and other news in brief: Alchemedicine, Antengene, Arrotex, Asahi Kasei, Chugai, Clinect, Daiichi Sankyo, Epredia, Formosa, Frontier, George Medicines, GrĂ¼nenthal, GSK, IDT Biologika, Jazz, Junshi, Mindpeak, Orient Europharma, Pfizer, PHC Holdings, Roche, Sarepta, Sciwind, SK Bioscience, Sumitomo, Sylamorebio, Vaxxas.
Read More

In the clinic for March 3, 2026

March 3, 2026
Clinical updates for biopharma and med tech in Asia-Pacific, including data readouts and publications: Argo, Immunexpress, Immvira, Novo Nordisk, Shionogi, United Laboratories International, Viiv.
Read More

Financings for March 3, 2026

March 3, 2026
Biopharma and med-tech companies in Asia-Pacific raising money in public or private financings: Respiree, Slate Medicines, Dartsbio.
Read More

Regulatory actions for March 2, 2026

March 2, 2026
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: AS Software, Asieris, Boehringer Ingelheim, Deephealth, Eli Lilly, Ipsen, Moderna, Neurogene, Novartis, Optellum, Photocure, Regeneron, Sanofi, Sentynl, Synergy Spine Solutions, X4.
Read More

Other news to note for March 2, 2026

March 2, 2026
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Candid Therapeutics, Rallybio.
Read More

In the clinic for March 2, 2026

March 2, 2026
Clinical updates for biopharma and med tech, including data readouts and publications: Adarx, Bayer, Blue Earth, Bluewind, Bonesupport, Curium, Galderma, Immvira, Johnson & Johnson, Organon, OSE, Urogen.
Read More

Financings for March 2, 2026

March 2, 2026
Biopharma and med-tech companies raising money in public or private financings, including: Boston Scientific, Braincheck, Medx, Penumbra, Zura.
Read More

Appointments and advancements for March 2, 2026

March 2, 2026
New hires and promotions in the biopharma and med-tech industries, including: Dexcom, Lohmann, Matricelf, Monod, Tidewave.
Read More

Biggest gainers and losers for Feb. 23-27, 2026

March 2, 2026
The top 10 biopharma stock gainers and losers for the week.
Read More

Money raised by biopharma

Feb. 27, 2026
Total raised in public, private and other financings of biopharma companies, comparing 2019-2026.
Read More
Previous 1 2 … 17 18 19 20 21 22 23 24 25 … 1781 1782 Next

Popular Stories

  • Today's news in brief

    BioWorld
  • MMP inhibitors divulged in Accure Therapeutics patent

    BioWorld Science
    Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for April 14, 2026
  • MSD discloses new HCN1/2 blockers

    BioWorld Science
    Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
  • Cancer cell in the cross-hairs

    Selective CBL-B inhibitor with improved safety profile disclosed

    BioWorld Science
    CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing